Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conor J Gallagher

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Aesthetic Surgery Journal|November 2, 2022
Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow PositionVince Bertucci, Jeremy B Green, John P Fezza, et al.
Aesthetic Surgery Journal|March 17, 2016
OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A ReviewAlastair Carruthers, Suzanne Bruce, Sue Ellen Cox, et al.
Journal of Drugs in Dermatology : JDD|July 23, 2019
Myths and Knowledge Gaps in the Aesthetic Treatment of Patients With Skin of ColorAndrew F. Alexis, Julius Few, Valerie D. Callender, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 9, 2019
Racial and Ethnic Differences in Self-Assessed Facial Aging in Women: Results From a Multinational StudyAndrew F Alexis, Pearl Grimes, Charles Boyd, et al.
Aesthetic Surgery Journal|April 13, 2023
Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar LinesShannon Humphrey, Jeffrey S Dover, Ronald R Bowsher, et al.
Plastic and Reconstructive Surgery. Global Open|February 26, 2026
Balanced Restoration: Optimizing Midface Rejuvenation Using Hyaluronic Acid FillersRod J Rohrich, Raul Cetto, Conor J Gallagher, et al.
Toxins|January 20, 2023
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 TrialsConor J Gallagher, Ronald R Bowsher, Amanda Clancy, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 31, 2014
Patient satisfaction and safety with aesthetic onabotulinumtoxinA after at least 5 years: a retrospective cross-sectional analysis of 4,402 glabellar treatmentsAda Trindade de Almeida, Jean Carruthers, Sue Ellen Cox, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 22, 2019
Lip and Perioral Enhancement With Hyaluronic Acid Dermal Fillers in Individuals With Skin of ColorSusan C Taylor, Jeanine B Downie, Ava Shamban, et al.
Aesthetic Surgery Journal|August 31, 2013
The South American Glabellar Experience Study (SAGE): a multicenter retrospective analysis of real-world treatment patterns following the introduction of incobotulinumtoxinA in ArgentinaRaúl A Banegas, Fernando Farache, Alberto Rancati, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Aesthetic Surgery Journal|November 2, 2022
Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow PositionVince Bertucci, Jeremy B Green, John P Fezza, et al.
Aesthetic Surgery Journal|March 17, 2016
OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A ReviewAlastair Carruthers, Suzanne Bruce, Sue Ellen Cox, et al.
Journal of Drugs in Dermatology : JDD|July 23, 2019
Myths and Knowledge Gaps in the Aesthetic Treatment of Patients With Skin of ColorAndrew F. Alexis, Julius Few, Valerie D. Callender, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 9, 2019
Racial and Ethnic Differences in Self-Assessed Facial Aging in Women: Results From a Multinational StudyAndrew F Alexis, Pearl Grimes, Charles Boyd, et al.
Aesthetic Surgery Journal|April 13, 2023
Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar LinesShannon Humphrey, Jeffrey S Dover, Ronald R Bowsher, et al.
Plastic and Reconstructive Surgery. Global Open|February 26, 2026
Balanced Restoration: Optimizing Midface Rejuvenation Using Hyaluronic Acid FillersRod J Rohrich, Raul Cetto, Conor J Gallagher, et al.
Toxins|January 20, 2023
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 TrialsConor J Gallagher, Ronald R Bowsher, Amanda Clancy, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 31, 2014
Patient satisfaction and safety with aesthetic onabotulinumtoxinA after at least 5 years: a retrospective cross-sectional analysis of 4,402 glabellar treatmentsAda Trindade de Almeida, Jean Carruthers, Sue Ellen Cox, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 22, 2019
Lip and Perioral Enhancement With Hyaluronic Acid Dermal Fillers in Individuals With Skin of ColorSusan C Taylor, Jeanine B Downie, Ava Shamban, et al.
Aesthetic Surgery Journal|August 31, 2013
The South American Glabellar Experience Study (SAGE): a multicenter retrospective analysis of real-world treatment patterns following the introduction of incobotulinumtoxinA in ArgentinaRaúl A Banegas, Fernando Farache, Alberto Rancati, et al.
Pageof 7